A recent study published in the journal Nature is attracting medical interest by suggesting a potential future shift in how insulin could be delivered. Researchers created a topical insulin formula applied to the skin that successfully lowered blood glucose in diabetic animals, with effects comparable to traditional injections.
Experimental Stage and Current Limitations
However, the research remains in the experimental stage and has only been tested on animals. It has not been evaluated in humans and does not currently replace injectable insulin used in diabetes treatment.
Despite this, the findings offer valuable insight into future directions for making diabetes care less invasive.
The team developed a special polymer designed to overcome the skin’s natural barrier, a major challenge for topical drug delivery. They combined this material with insulin and tested it on diabetic mice and minipigs.
After application, the insulin was able to pass through the skin, enter the bloodstream, and rapidly lower blood glucose levels, acting similarly to fast-acting injectable insulin.
Current Methods of Insulin Delivery and Their Challenges
Currently, insulin is being delivered mainly through injections or infusion pumps, which can be uncomfortable and may cause needle anxiety, making it harder for some patients to stick to their treatment plans.
A topical option, if it is eventually proven safe and effective in humans, could:
– Lower the need for injections
– Make treatment easier for people with needle phobia
– Improve adherence to diabetes care
– Broaden future treatment possibilities
However, the researchers stress that these advantages remain hypothetical at this stage.
Required Steps Before Clinical Use
Before it can be considered for clinical use, the technology must undergo multiple steps, including:
– Further safety evaluations
– Controlled human clinical trials
– Assessment of dosage, duration of action, and potential side effects
– Regulatory review and approval
This process typically takes many years, and results seen in animal studies are not always replicated in humans.
In practical terms, there is no change for now. Insulin therapy still relies on injections or infusion devices, as prescribed by healthcare professionals.
Ongoing Advances in Diabetes Research
Nevertheless, the study highlights that research continues to seek safer, more comfortable, and more personalized diabetes treatments.
The so-called “cream insulin” is not yet a clinical option, but it represents an important step forward in scientific research. By understanding its current stage and limitations, it is possible to view the development with optimism, without raising unrealistic expectations.
Read the original article on:umdiabetico
Read more:Researchers are testing transparent wood as a glass alternative